See All Clinical Studies

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.

Intervention:

Drug: Tolvaptan

Participation criteria:

Inclusion criteria:

  • diagnosed ADPKD
  • total kidney volume of 750 or more

Contact information:

Drug Information Center
+81-3-6361-7314